This content is machine translated Breast Cancer HER2-negative breast cancer in a pot with triple-negative tumors? One study suggests that patients with low HR-positive/HER2-negative tumors could be considered and treated similarly to patients with triple-negative tumors. Should the current definitions of HR positivity and their clinical…
View Post 7 min This content is machine translated New therapies Progress in metastatic malignant melanoma New insights in tumor biology and immunology as well as in molecular pathology have rapidly driven the development of immunomodulatory antibodies and so-called “targeted” therapeutics [1]. This makes the therapy…
View Post 8 min This content is machine translated New therapies Progress in metastatic malignant melanoma New insights in tumor biology and immunology as well as in molecular pathology have rapidly driven the development of immunomodulatory antibodies and so-called “targeted” therapeutics [1]. This makes the therapy…
